R01 DA035714/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2011	1
2013	2
2014	3
2015	8
2016	6
2017	2
2018	3
2019	2
2020	3
2021	4
2022	5
2023	3
2024	2

1

The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases.

Davis SE, Cirincione AB, Jimenez-Torres AC, Zhu J. Davis SE, et al. Int J Mol Sci. 2023 Oct 19;24(20):15340. doi: 10.3390/ijms242015340. Int J Mol Sci. 2023. PMID: 37895020 Free PMC article. Review.

2

Substance abuse and neurotransmission.

Davis S, Zhu J. Davis S, et al. Adv Pharmacol. 2022;93:403-441. doi: 10.1016/bs.apha.2021.10.007. Epub 2022 Jan 17. Adv Pharmacol. 2022. PMID: 35341573 Free PMC article.

3

The role of human dopamine transporter in NeuroAIDS.

Zhu J, Ananthan S, Zhan CG. Zhu J, et al. Pharmacol Ther. 2018 Mar;183:78-89. doi: 10.1016/j.pharmthera.2017.10.007. Epub 2017 Oct 5. Pharmacol Ther. 2018. PMID: 28987321 Free PMC article. Review.

4

Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.

Sun WL, Quizon PM, Zhu J. Sun WL, et al. Prog Mol Biol Transl Sci. 2016;137:1-40. doi: 10.1016/bs.pmbts.2015.10.017. Epub 2015 Nov 17. Prog Mol Biol Transl Sci. 2016. PMID: 26809997 Free PMC article. Review.

5

Mini review: Promotion of substance abuse in HIV patients: Biological mediation by HIV-1 Tat protein.

Cirino TJ, McLaughlin JP. Cirino TJ, et al. Neurosci Lett. 2021 May 14;753:135877. doi: 10.1016/j.neulet.2021.135877. Epub 2021 Apr 7. Neurosci Lett. 2021. PMID: 33838257 Review.

6

Viral mechanisms: Tat modulates DAT.

Bucci M. Bucci M. Nat Chem Biol. 2015 Apr;11(4):240. doi: 10.1038/nchembio.1779. Nat Chem Biol. 2015. PMID: 25785419 Free PMC article. No abstract available.

7

Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat.

Adeniran C, Yuan Y, Davis SE, Lin C, Xu J, Zhu J, Zhan CG. Adeniran C, et al. ACS Chem Neurosci. 2021 May 5;12(9):1519-1527. doi: 10.1021/acschemneuro.0c00792. Epub 2021 Apr 22. ACS Chem Neurosci. 2021. PMID: 33886267 Free PMC article.

8

Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.

Yuan Y, Huang X, Midde NM, Quizon PM, Sun WL, Zhu J, Zhan CG. Yuan Y, et al. ACS Chem Neurosci. 2015 Apr 15;6(4):658-665. doi: 10.1021/acschemneuro.5b00001. Epub 2015 Feb 19. ACS Chem Neurosci. 2015. PMID: 25695767 Free PMC article.

9

Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.

Midde NM, Yuan Y, Quizon PM, Sun WL, Huang X, Zhan CG, Zhu J. Midde NM, et al. J Neuroimmune Pharmacol. 2015 Mar;10(1):122-35. doi: 10.1007/s11481-015-9583-3. Epub 2015 Jan 22. J Neuroimmune Pharmacol. 2015. PMID: 25604666 Free PMC article.

10

Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.

Bertrand SJ, Mactutus CF, Aksenova MV, Espensen-Sturges TD, Booze RM. Bertrand SJ, et al. J Neurochem. 2014 Jan;128(1):140-51. doi: 10.1111/jnc.12375. Epub 2013 Aug 26. J Neurochem. 2014. PMID: 23875777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year